Latest News About Hims Stock

Here’s a quick snapshot of the latest publicly available news on Hims & Hers Health (HIMS) stock as of now.

• Recent headlines highlight continued attention on international expansion and buyback activity. For example, reports in mid-2025 covered HIMS pursuing international growth, including Europe, and discussing a share repurchase program, which can influence investor sentiment and stock movement.[1][2]
• Other outlets in late 2025 noted stock responses to expansion news (Canada entry, new product lines, and acquisitions in testing and diagnostics), with shares fluctuating on earnings and guidance details. This suggests the stock remains sensitive to strategic steps and near-term profitability signals.[2][3]
• Market trackers and financial news sites show ongoing coverage of HIMS stock, including price movements around major announcements and analyst commentary, though opinions on valuation and risk remain mixed.[5][9][10]

If you’d like, I can pull the very latest items from specific sources (e.g., Yahoo Finance, MarketBeat, Reuters) and summarize the key price moves, catalysts, and analyst targets. Would you like a short list of the most recent five headlines with a quick price context?

Note: For precise up-to-the-minute data, please confirm you want me to fetch current quotes and the latest articles, and I’ll pull them and cite them.